Shares of ARS Pharmaceuticals (NASDAQ:SPRY) rose 13% Friday after the company announced it had received FDA approval for its epinephrine nasal spray for the treatment of severe allergic reactions.

Melatonin, lavender and chamomile help lure you to dreamland lickety-split, fans say: 'I drifted off without tossing and turning.' ...